课题基金 / 基金详情

RHO GTPASES AND ACTIN FUNCTION IN RENAL ISCHEMIA

RHO GTPASES AND ACTIN FUNCTION IN RENAL ISCHEMIA
肾缺血中的 RHO GT 酶和肌动蛋白功能
批准号:
6617845
负责人:
Simon J. Atkinson
金额:
$23.0万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-07-01 至 2006-06-30

项目摘要

项目成果

Simon J. Atkinson的其他基金

相似基金

相关文献

中文摘要
翻译
缺血性急性肾功能衰竭是发病率和死亡率的主要原因。肾近端小管的细胞特别容易受到缺血性损伤,这种损伤的特征是正常细胞结构的破坏,从而导致表面蛋白质极化分布的丧失。这种细胞结构和功能的破坏与肌动蛋白细胞骨架成分的快速和可逆的重新分配有关。我们认为这种肌动蛋白丝的异常分布是由rho家族gtpase失活引起的。Rho蛋白是调节细胞形态和运动的小gtpase ras超家族的分支,其在成纤维细胞中控制肌动蛋白功能的作用已被广泛研究,但在上皮细胞中尚未被充分表征。我们提出了三个特定的目的来测试rho蛋白及其效应物在缺血细胞培养模型中参与肌动蛋白重组,使用底物消耗和抗霉素a治疗诱导ATP消耗。我们将使用显微注射和转染将Rho、Rac和Cdc42的显性活性和显性阴性突变体引入LLC-PK细胞,以测试通过这些蛋白质阻断失活或激活途径对肌动蛋白细胞骨架对ATP耗尽或恢复的反应的影响。我们将通过测量GTP:GDP与GTPase结合的比率来测量rho家族GTPase在ATP耗尽和恢复条件下的激活状态,并使用GTP标记的蛋白质分析GTPase的细胞定位。肌球蛋白II的细胞质同工型在极化上皮中肌动蛋白细胞骨架的功能中起重要作用,是Rho调控的重要靶点。我们将在对照细胞中检测肌凝蛋白定位和轻链磷酸化,以及ATP消耗和ezrin调节的响应,我们将使用显性阴性和组成型活性突变体确定肌凝蛋白活性、rho激酶和肌凝蛋白轻链激酶(MLCK)的调节因子的影响。从这些研究中获得的数据将为理解细胞骨架对缺血异常反应的细胞机制以及已知生长因子有益作用的机制提供基础。这将为改进治疗方法的发展提供基础,以管理人类缺血性急性肾功能衰竭。
英文摘要
Ischemic acute renal failure is a major cause of morbidity and mortality. Cells of the kidney proximal tubule are particularly vulnerable to ischemic injury, and this injury is characterized by breakdown of normal cellular architecture with consequent loss of polarized distribution of surface proteins. This disruption of cell structure and function correlates with rapid and reversible redistribution of components of the actin cytoskeleton. We propose that this abnormal distribution of actin filaments results from inactivation of rho family GTPases. Rho proteins are the branch of the ras superfamily of small GTPases that regulate cell morphology and motility, and their role in controlling actin function has been extensively studied in fibroblasts, but is less well characterized in epithelial cells. We propose three specific aims to test the involvement of rho proteins and their effectors in actin reorganization in a cell culture model of ischemia, using ATP depletion induced by substrate depletion and antimycin A treatment. We will use microinjection and transfection to introduce dominant active and dominant negative mutants of Rho, Rac and Cdc42 into LLC-PK cells to test the effect of blocking inactivation or activation of pathways through these proteins on the actin cytoskeletal response to ATP depletion or recovery. We will measure the activation state of rho family GTPases under conditions of ATP depletion and recovery by measuring the ratio of GTP:GDP bound to the GTPase, and analysing cellular localization of the GTPase using GFP-tagged proteins. Cytoplasmic isoforms of myosin II play an important role in function of the actin cytoskeleton in polarized epithelia, and are an important target of Rho regulation. We will examine myosin localization and light chain phosphorylation in control cells and in response to ATP depletion, and ezrin regulation, and we will determine the effect of regulators of myosin activity, Rho-kinase and myosin light chain kinase (MLCK), using dominant negative and constitutively active mutants. The data derived from the proposed studies will provide a basis for understanding the cellular mechanisms that underlie the abnormal response of the cytoskeleton to ischemia, and a mechanism for the known beneficial effects of growth factors. This will provide a basis for the development of improved therapeutic approaches to the management of human ischemic acute renal failure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Utilizing siRNA to Minimize Nephrotoxic Injury
Utilizing siRNA to Minimize Nephrotoxic Injury
Utilizing siRNA to Minimize Nephrotoxic Injury
Utilizing siRNA to Minimize Nephrotoxic Injury
海外基金